Indian pharma specialist ACG Inspection moves to Y-Parc
Yverdon hosts an Indian pharma company. ACG Inspection is expected to occupy about fifty employees, for an investment of 5 million francs after three years.
"The goal is to create a center of excellence for sales, services, research and development (R & D), including employing qualified engineers and taking advantage of the proximity of several pharmaceutical companies and universities in the region, "said François Bangerter, head of sales for Europe of the company, on the sidelines of the inauguration made in the presence in particular of the State Councilor vaudois Philippe Leuba.
ACG Inspection deals in particular with the traceability of pharmaceutical products, with new technologies enabling manufacturers to comply with the regulations on counterfeits. In the medium term, the blockchain must make it possible to support these efforts of security. The control of the packaging and the verification of the caps on the bottles are also included in the development axes.
For Y-Parc, this arrival represents a "strengthening of its life sciences sector," said a statement. The Yverdon Park hosts some 170 companies, representing 1580 jobs. The park is pleased to have been selected after an ACG analysis of several potential competitor sites, both abroad and in Switzerland.
At the Waldensian level, the "Health Valley" has about 400 companies and a total of 20'000 jobs. Among the criteria, in addition to skilled labor, taxation and location played a role, said François Bangerter.
ACG Inspection is one of four units of the ACG Group, based in Mumbai, which employs around 5,000 people worldwide. The group specializes in manufacturing and designing packaging solutions for the pharmaceutical industry (capsules for example). In 2017, its turnover reached 420 million francs. (Awp)